Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial

OBJECTIVE: To evaluate the efficacy and safety of metformin in the treatment of amisulpride-induced hyperprolactinemia. METHODS: A total of 86 schizophrenic patients who developed hyperprolactinemia after taking amisulpride were screened and randomly assigned to the metformin group (42 patients) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Cuifang, Li, Ruofan, Ju, Mingliang, Xiao, Xudong, Yuan, Ti-Fei, Jin, Zhixing, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205636/
https://www.ncbi.nlm.nih.gov/pubmed/35721320
http://dx.doi.org/10.3389/fnmol.2022.892477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205636/
https://www.ncbi.nlm.nih.gov/pubmed/35721320
http://dx.doi.org/10.3389/fnmol.2022.892477

Ejemplares similares